Chelsea And Westminster Nhs Foundation Trust

This study followed 200 transgender and non-binary people living with HIV across Europe for 18 months. Researchers collected data from routine blood tests to see how well HIV treatment was working. The goal was to learn more about this group's health needs and help design better …

This study looked at how dolutegravir, an HIV medication, changes the way the body handles sugar, fats, and hormones. Sixteen healthy HIV-negative volunteers took the drug and were monitored for insulin resistance and other metabolic changes. The goal was to understand why some p…